Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH AL 2020 | MicroRNA-181a: a novel marker of CNS involvement in pediatric ALL

Dániel János Erdélyi • 29 Jun 2020
ESH AL 2020
Acute Lymphoblastic Leukemia Leukemia

Dániel János Erdélyi, PhD, Semmelweis University, Budapest, Hungary, discusses microRNA-181a as a novel liquid biopsy marker of central nervous system (CNS) involvement in pediatric acute lymphoblastic leukemia (ALL). Dr János Erdélyi reveals that microRNA-181a might be a novel tool for monitoring CNS disease course and adjusting CNS-directed therapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Dániel János Erdélyi

5:19
Circulating microRNAs as MRD biomarkers in pediatric ALL
Dániel János Erdélyi • 29 Jun 2020

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals